300676 华大基因
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(181,354)(63,215)95,723408,768130,883
投资活动产生之现金流量净额85,810(1,025,189)(314,416)(1,750,741)(580,074)
筹资活动产生之现金流量净额(40,773)149,859(683,152)(266,882)(1,194,537)
汇率变动对现金及现金等价物的影响(17,035)(1,551)45,12132,822279,379
现金及现金等价物净增加/(减少)(153,352)(940,096)(856,724)(1,576,033)(1,364,349)
期初现金及现金等价物余额1,758,3212,698,4173,555,1415,131,1746,495,523
期末现金及现金等价物余额1,604,9701,758,3212,698,4173,555,1415,131,174